Literature DB >> 16557604

Potential synergism of natural products in the treatment of cancer.

S HemaIswarya1, Mukesh Doble.   

Abstract

Cancer is the second leading cause of death worldwide. There is thus increased interest in alternative treatment modalities that include chemotherapy, hormonal supplements, surgery, radiation therapy, complementary or alterative medicine, used alone or in combination. Therefore patients who are subjected to combination treatments such as hormonal supplements or alternative medicine face considerable risk of drug-drug interactions. The administration of herbal drugs by patients without a physician's prior counseling is increasing globally and there is a possibility of herb-drug interactions too. Herbal drugs or extracts themselves contain a combination of active constituents, which interact within themselves and also between other prescribed pharmaceutical drugs to either enhance (synergize) or decrease (antagonize) the therapeutic effect. This review focuses on a number of reports of herb-drug interactions, their mechanism of action with a special emphasis on dietetic phytochemicals such as quercetin, genistein, curcumin and catechins. All phytochemicals tend to increase the therapeutic effect by blocking one or more targets of the signal transduction pathway, by increasing the bioavailability of the other drug or, by stabilizing the other drug in the system. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557604     DOI: 10.1002/ptr.1841

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  58 in total

Review 1.  Herbal medicine as inducers of apoptosis in cancer treatment.

Authors:  Elham Safarzadeh; Siamak Sandoghchian Shotorbani; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-25

Review 2.  Mechanisms of combined action of different chemopreventive dietary compounds: a review.

Authors:  Theo M de Kok; Simone G van Breda; Margaret M Manson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

3.  Antibacterial activity of selected invertebrate species.

Authors:  Salwa Mansur Ali; Ruqaiyayh Siddiqui; Kuppusamy A Sagathevan; Naveed Ahmed Khan
Journal:  Folia Microbiol (Praha)       Date:  2021-03-11       Impact factor: 2.099

4.  Naphthoquinone components from Alkanna tinctoria (L.) Tausch show significant antiproliferative effects on human colorectal cancer cells.

Authors:  Nguyen Huu Tung; Guang-Jian Du; Chong-Zhi Wang; Chun-Su Yuan; Yukihiro Shoyama
Journal:  Phytother Res       Date:  2012-04-04       Impact factor: 5.878

5.  What is Xenohormesis?

Authors:  Joseph A Baur; David A Sinclair
Journal:  Am J Pharmacol Toxicol       Date:  2008-03-31

6.  Evaluation of synergistic effects of sulforaphene with photodynamic therapy in human cervical cancer cell line.

Authors:  R Biswas; A Mondal; S Chatterjee; J C Ahn
Journal:  Lasers Med Sci       Date:  2016-08-03       Impact factor: 3.161

7.  Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract.

Authors:  Sushma R Gundala; Rao Mukkavilli; Chunhua Yang; Pooja Yadav; Vibha Tandon; Subrahmanyam Vangala; Satya Prakash; Ritu Aneja
Journal:  Carcinogenesis       Date:  2014-01-15       Impact factor: 4.944

8.  Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation.

Authors:  Meera Brahmbhatt; Sushma R Gundala; Ghazia Asif; Shahab A Shamsi; Ritu Aneja
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

9.  Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.

Authors:  Sara M Johnson; Xiaofu Wang; B Mark Evers
Journal:  J Surg Res       Date:  2009-08-05       Impact factor: 2.192

10.  Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells.

Authors:  H H Aung; C Z Wang; M Ni; A Fishbein; S R Mehendale; J T Xie; C Y Shoyama; C S Yuan
Journal:  Exp Oncol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.